334
Participants
Start Date
January 31, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
August 31, 2015
LDV/SOF
LDV/SOF FDC tablet administered orally once daily
RBV
RBV tablets administered orally in a divided daily dose
Auckland City Hospital, Auckland
Medizinische Universitat Wien, Vienna
UCL St-Luc Brussels, Brussels
Royal Prince Alfred Hospital, University of Sydney, Camperdown
University of Berne, Bern
Austin Repatriation Hospital (Melbourne) // Victorian Transplant Centre, Heidelberg
Hospital General Universitari Vall d' Hebron, Barcelona
Hospital Clinic i Provincial, Barcelona
Universitair Ziekenhuis Gent, Ghent
Azienda Ospedaliera San Giovanni, Battista di Torino \\ Professor of Gastroenterology-San Giovanni Battista Hospital-University of Torino, Torino
IRCCS Cà Grande Ospedale Maggiore Policlinico, Milan
Puerta de Hierro, Madrid, Madrid
Medical School of Hannover, Hanover
Hopital Saint-Eloi, Montpellier
Universitätsklinikum Essen - klinikum für Gastroenterolgie und Hepatologie, Essen
Hospital Universitario y Politecnico La Fe de Valencia, Valencia
Universitätsklinikum RWTH Aachen, Aachen
University Hospital Johann Wolfgang Goethe University, Department of Internal Medicine I, Frankfurt
Hospital Beaujon, Clichy
Hospital Mondor \\ Service d'Hépatologie et de Gastroentérologie,, Créteil
Hopital Paul Brousse, Villejuif
Medizinische Universitaet Innsbruck, Innsbruck
Division of Gastroenterology, University of Alberta, Edmonton, Edmonton
University of British Columbia and Vancouver General Hospital, Vancouver
London Health Sciences Centre-University Hospital, London
University Health Network // Toronto General Hospital, Toronto
Hopital St. Luc, Montreal
McGill University Health Centre \\ Royal Victoria Hospital, Montreal
Leids Universitair Medisch Centrum, Leiden
Erasmus MC in Rotterdam, Rotterdam
University Hospital Zurich, Zurich
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Royal Infirmary of Edinburgh \\ Scottish Liver Transplant Unit-Edinburgh, Edinburgh
Kings College Hospital, Institute of Liver Studies, London
Lead Sponsor
Gilead Sciences
INDUSTRY